Every cell and gene therapy is unique - and your commercialization plan should be too. That's why McKesson brings a suite of configurable CGT solutions, giving you the flexibility to meet the immediate market needs and to scale for future growth.
Our suite of services includes:
- Channel strategy solutions including a trusted 3PL with proven experience with cell and gene therapies
- Patient access services including a CGT specialty pharmacy and a CGT specific hub enabling an integrated approach
- Provider solutions to streamline and support CGT adoption among HCPs
- Coverage and reimbursement solutions and expertise on innovative payment models to drive broader patient access
- Clinical and commercial enablement to accelerate the future success of your product
McKesson understands the complex cell and gene therapy supply chain. Our high-touch services are designed to enhance patient outcomes, mitigate financial burdens, and generate data to drive sustainable success.
Backed by real-world experience and unparalleled breadth of resources, our CGT portfolio of work includes:
- Collaboration with cell and gene therapy sponsors since 2010
- >100 clinical trials for CGT products
- Relationships with >95% of active CGT sites of care
Cell and gene therapies are the future of medicine - and McKesson is dedicated to helping you to realize that potential.
Connect with us to learn more about how we can be your enduring ally, empowering you to transform and save lives.
